Development of a midlife-specific CogDrisk algorithm (CogDrisk-ML) to enable validated implementation of dementia risk assessment from midlife to late life.
Md Hamidul Huque, Heidi Jane Welberry, Ranmalee Eramudugolla, Nicola T Lautenschlager, Kaarin J Anstey
{"title":"Development of a midlife-specific CogDrisk algorithm (CogDrisk-ML) to enable validated implementation of dementia risk assessment from midlife to late life.","authors":"Md Hamidul Huque, Heidi Jane Welberry, Ranmalee Eramudugolla, Nicola T Lautenschlager, Kaarin J Anstey","doi":"10.1093/ageing/afaf201","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Existing dementia risk assessment tools, such as The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI), LIfestyle for BRAin health (LIBRA) and Cognitive health and Dementia Risk Assessment (CogDrisk), show limited validation for middle-aged adults (age 40-64 years). The Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) tool, developed almost two decades ago, demonstrated moderate predictive accuracy. As key modifiable dementia risk factors emerge in midlife, there is a need for a new, more accurate midlife dementia risk assessment tool.</p><p><strong>Objectives: </strong>To develop CogDrisk-ML, a midlife dementia risk assessment tool that can complement the existing CogDrisk tool for late-life dementia risk assessment.</p><p><strong>Design and settings: </strong>Data from the UK Biobank and the Atherosclerosis Risk in Communities (ARIC) study were used to develop and validate CogDrisk-ML, which was also externally validated using the Whitehall II cohort.</p><p><strong>Participants and covariates: </strong>Participants without dementia at baseline were included, with CogDrisk predictors along with additional midlife risk factors based on recent evidence.</p><p><strong>Main outcome measures: </strong>Cox regression models estimated the relationship between risk factors and dementia for each sex. A random-effects meta-analysis model aggregated cohort- and sex-specific regression coefficients to develop CogDrisk-ML. Harrell's C statistics measured predictability, with multiple imputation used for missing data.</p><p><strong>Results: </strong>CogDrisk-ML outperformed CAIDE in the UK Biobank and Whitehall II cohorts; however, it provided similar C statistics in the ARIC dataset. C statistics (95% confidence interval) for CogDrisk-ML were 0.71 (0.69, 0.74) for the ARIC, 0.75 (0.73, 0.77) for the UK Biobank and 0.70 (0.62, 0.79) for the Whitehall II study.</p><p><strong>Conclusion: </strong>The novel CogDrisk-ML for assessing dementia risk in midlife offers improved predictive accuracy. Combined with the CogDrisk tool for late life, it provides a comprehensive framework for dementia prevention throughout the life course.</p>","PeriodicalId":7682,"journal":{"name":"Age and ageing","volume":"54 7","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12277239/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Age and ageing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ageing/afaf201","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Existing dementia risk assessment tools, such as The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI), LIfestyle for BRAin health (LIBRA) and Cognitive health and Dementia Risk Assessment (CogDrisk), show limited validation for middle-aged adults (age 40-64 years). The Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) tool, developed almost two decades ago, demonstrated moderate predictive accuracy. As key modifiable dementia risk factors emerge in midlife, there is a need for a new, more accurate midlife dementia risk assessment tool.
Objectives: To develop CogDrisk-ML, a midlife dementia risk assessment tool that can complement the existing CogDrisk tool for late-life dementia risk assessment.
Design and settings: Data from the UK Biobank and the Atherosclerosis Risk in Communities (ARIC) study were used to develop and validate CogDrisk-ML, which was also externally validated using the Whitehall II cohort.
Participants and covariates: Participants without dementia at baseline were included, with CogDrisk predictors along with additional midlife risk factors based on recent evidence.
Main outcome measures: Cox regression models estimated the relationship between risk factors and dementia for each sex. A random-effects meta-analysis model aggregated cohort- and sex-specific regression coefficients to develop CogDrisk-ML. Harrell's C statistics measured predictability, with multiple imputation used for missing data.
Results: CogDrisk-ML outperformed CAIDE in the UK Biobank and Whitehall II cohorts; however, it provided similar C statistics in the ARIC dataset. C statistics (95% confidence interval) for CogDrisk-ML were 0.71 (0.69, 0.74) for the ARIC, 0.75 (0.73, 0.77) for the UK Biobank and 0.70 (0.62, 0.79) for the Whitehall II study.
Conclusion: The novel CogDrisk-ML for assessing dementia risk in midlife offers improved predictive accuracy. Combined with the CogDrisk tool for late life, it provides a comprehensive framework for dementia prevention throughout the life course.
期刊介绍:
Age and Ageing is an international journal publishing refereed original articles and commissioned reviews on geriatric medicine and gerontology. Its range includes research on ageing and clinical, epidemiological, and psychological aspects of later life.